Metrics
- Price
- $79.89
- Market Cap $M
- N/A
- Rel Volume
- 0.78
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- +3.90%
- 1D
- +0.77%
- 1W
- +0.11%
- 1M
- +2.32%
- 1M Slope
- +3.67%
- 6M Range
- 90.62%
- Score
- 83.5
- Sharp
- 10.1
Volume
Profile
Kiniksa Pharmaceuticals develops and commercializes therapies for autoimmune and inflammatory diseases, with a focus on biologic medicines for rare and chronic immune conditions.
Healthcare
Biotech
Pharmaceuticals